Quarterly report pursuant to Section 13 or 15(d)

Statements of Operations (Unaudited)

v3.23.2
Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Operating expenses:        
Research and development $ 838,931 $ 1,612,552 $ 2,031,564 $ 3,208,391
General and administrative 893,483 1,118,021 1,978,532 2,308,334
Total operating expenses 1,732,414 2,730,573 4,010,096 5,516,725
Loss from operations (1,732,414) (2,730,573) (4,010,096) (5,516,725)
Other income and expenses:        
Interest income, net 31,050 0 68,590 0
Net loss $ (1,701,364) $ (2,730,573) $ (3,941,506) $ (5,516,725)
Net loss per share of common stock, basic and diluted $ (0.63) $ (3.90) $ (2.13) $ (9.02)
Weighted-average basic and diluted common shares $ 2,704,987 $ 699,679 $ 1,850,167 $ 611,344